| MLORX | SPMHX | MLORX / SPMHX | |
| Total Expense Ratio | 1.40 | 6.29 | 22% |
| Annual Report Gross Expense Ratio | 1.80 | 6.29 | 29% |
| Fund Existence | 11 years | 6 years | - |
| Gain YTD | 18.600 | 2.871 | 648% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 122M | 1.03B | 12% |
| Annual Yield % from dividends | 3.94 | 5.71 | 69% |
| Returns for 1 year | 13.44 | 1.54 | 871% |
| Returns for 3 years | 39.86 | 72.06 | 55% |
| Returns for 5 years | 156.19 | 224.78 | 69% |
| Returns for 10 years | 107.97 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FGSIX | 66.63 | 0.07 | +0.11% |
| Federated Hermes MDT Mid Cap Growth IS | |||
| CNPIX | 69.76 | N/A | N/A |
| Consumer Staples UltraSector ProFund Inv | |||
| VEIGX | 37.81 | N/A | N/A |
| Vanguard Global ESG Select Stk Investor | |||
| IVGSX | 19.62 | -0.03 | -0.15% |
| VY® Invesco Growth and Income S | |||
| BRWCX | 26.59 | -0.30 | -1.12% |
| MFS Blended Research Growth Eq C | |||